Host Cell Death Responses to Non-typhoidal Salmonella Infection
subsp. serovar Typhimurium ( . Typhimurium) is a Gram-negative bacterium with a broad host range that causes non-typhoidal salmonellosis in humans. . Typhimurium infects epithelial cells and macrophages in the small intestine where it replicates in a specialized intracellular niche called the -conta...
Saved in:
Published in: | Frontiers in immunology Vol. 10; p. 1758 |
---|---|
Main Authors: | , |
Format: | Journal Article |
Language: | English |
Published: |
Switzerland
Frontiers Media S.A
26-07-2019
|
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | subsp.
serovar Typhimurium (
. Typhimurium) is a Gram-negative bacterium with a broad host range that causes non-typhoidal salmonellosis in humans.
. Typhimurium infects epithelial cells and macrophages in the small intestine where it replicates in a specialized intracellular niche called the
-containing vacuole (SCV) and promotes inflammation of the mucosa to induce typically self-limiting gastroenteritis. Virulence and spread of the bacterium is determined in part by the host individual's ability to limit the infection through innate immune responses at the gastrointestinal mucosa, including programmed cell death.
. Typhimurium however, has evolved a myriad of mechanisms to counteract or exploit host responses through the use of Type III Secretion Systems (T3SS), which allow the translocation of virulence (effector) proteins into the host cell for the benefit of optimal bacterial replication and dissemination. T3SS effectors have been found to interact with apoptotic, necroptotic, and pyroptotic cell death cascades, interfering with both efficient clearance of the bacteria and the recruitment of neutrophils or dendritic cells to the area of infection. The interplay of host inflammation, programmed cell death responses, and bacterial defenses in the context of non-typhoidal
(NTS) infection is a continuing area of interest within the field, and as such has been reviewed here. |
---|---|
Bibliography: | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-3 content type line 23 ObjectType-Review-1 This article was submitted to Microbial Immunology, a section of the journal Frontiers in Immunology Present address: Madeleine A. Wemyss and Jaclyn S. Pearson, Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, VIC, Australia Edited by: Barbara Bottazzi, Milan University, Italy Reviewed by: Silvia Guglietta, Medical University of South Carolina, United States; Elsa Anes, University of Lisbon, Portugal |
ISSN: | 1664-3224 1664-3224 |
DOI: | 10.3389/fimmu.2019.01758 |